Results 111 to 120 of about 105,468 (155)

Chinese dragon's blood ethyl acetate extract suppresses gastric cancer progression through induction of apoptosis and autophagy mediated by activation of MAPK and downregulation of the mTOR‐Beclin1 signalling cascade

Phytotherapy Research, 2022
Gastric cancer (GC) is a malignancy with high morbidity and mortality. Chinese dragon's blood is a traditional Chinese medicine derived from the red resin of Dracaena cochinchinensis (Lour.) S. C. Chen.
Lishan Ouyang, Jiaqi Li, Xiaonan Chen, Huiming Huang, Yingying Tian, Xingxing Li, Daoran Pang, Xuejiao Wei, Jinxin Xie, Longyan Wang, Dongxiao Liu, P. Tu, Jun Li, Zhongdong Hu   +13 more
semanticscholar   +1 more source

Loureirin C, from Chinese Dragon's Blood (Dracaena cochinchinensis S.C. Chen), is a novel selective estrogen receptor α modulator with anti-Alzheimer's disease effects.

Fitoterapia, 2023
As the incidence of Alzheimer's disease (AD) continues to rise in recent years, there are few therapeutic drugs for AD treatment with limited efficacy.
P. Xu, Shaoyun Li, Qing Wu, Luxi Yang, Na Zheng, Chao Zhu, P. Liu, Ning Li, L. Zou   +8 more
semanticscholar   +1 more source

Trimeric chalchonoids from the total phenolic extract of Chinese dragon's blood (the red resin of Dracaena cochinchinensis).

Fitoterapia, 2021
Four new chalchonoid trimers, named cochinchinenins N-Q (1-4), along with a pair of known enantiomers (5-6), were isolated from the total phenolic extract of Chinese dragon's blood (the red resin of Dracaena cochinchinensis). The planar structures of 1-4
Dao-ran Pang, Qiu-Yu Zou, Zhixiang Zhu, Xinyu Wang, Yuying Pei, Hui-xia Huo, Yun-fang Zhao, P. Tu, Jiao Zheng, Jun Li   +9 more
semanticscholar   +1 more source

Pharmacoproteomics reveals the mechanism of Chinese dragon's blood in regulating the RSK/TSC2/mTOR/ribosome pathway in alleviation of DSS-induced acute ulcerative colitis.

Journal of Ethnopharmacology, 2020
ETHNOPHARMACOLOGICAL RELEVANCE Chinese dragon's blood (CDB), a crude drug extracted from Dracaena cochinchinensis (Lour.) S.C. Chen, has been historically applied for the treatment of various diseases, including ulcerative colitis (UC).
Yilong Lin, Wanna Xiong, S. Xiao, Fang Li, Zhu Lu, Jiongyi Yan, Xuewan Fang, Xiaojuan Cui, Yi-Lei Wen, Jianqin Liang, Kai Yu   +10 more
semanticscholar   +1 more source

Bioactive flavonoid dimers from Chinese dragon's blood, the red resin of Dracaena cochinchinensis.

Bioorganic chemistry (Print), 2020
Seven flavonoid dimers, biflavocochins A-G, together with six known compounds were isolated from the red resins of Dracaena cochinchinensis (Chinese dragon's blood). Their structures were elucidated based on extensive spectroscopic analysis. The absolute
Guang-Zhen Lang, Chuang-jun Li, Tong-Yue Gaohu, Chuang-jun Li, Jie Ma, Jing-zhi Yang, Tian-tian Zhou, Yu-he Yuan, Fei Ye, Jian-He Wei, Dong‐ming Zhang   +10 more
semanticscholar   +1 more source

Dragon's Blood from Dracaena Worldwide: Species, Traditional Uses, Phytochemistry and Pharmacology.

The American Journal of Chinese Medicine, 2021
Dragon's blood (DB) refers mainly to the crimson resin of many Dracaena spp. DB has been used by different traditional medicine systems worldwide, including Arabic medicine, African medicine, traditional Chinese medicine, Thai medicine, etc.
Yang Liu, Xiangsheng Zhao, Ruyu Yao, Chuang-jun Li, Zhonglian Zhang, Yanhong Xu, Jian-He Wei   +6 more
semanticscholar   +1 more source

Dragon's Blood exerts cardio-protection against myocardial injury through PI3K-AKT-mTOR signaling pathway in acute myocardial infarction mice model.

Journal of Ethnopharmacology, 2018
ETHNOPHARMACOLOGICAL RELEVANCE Dragon's Blood (DB), the red resin of Dracaena cochinchinensis (Lour.) S. C., has been used in traditional Chinese medicine to treat acute myocardial infarction (AMI) for centuries.
Chun Li, Yi Zhang, Qiyan Wang, Hui Meng, Qian Zhang, Yan Wu, W. Xiao, Yong Wang, P. Tu   +8 more
semanticscholar   +1 more source

[Research progress on anti-tumor effect of Chinese dragon's blood].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2021
Yingying Tian, A. Yang, Xiaonan Chen, Jia-qi Li, Lei-Meng-Yuan Tang, Huiming Huang, Ya-Xin Liu, Hai-Ling Qiu, Lishan Ouyang, Jun Li, P. Tu, Zhongdong Hu   +11 more
semanticscholar   +1 more source

Enzymatically Biotransformed Compounds via a Predicted Data Mining Approach: Two Novel Flavonoids, 3’-Hydroxyloureirin A and 3’-Hydroxyloureirin B, Converted from Dragon’s Blood, the Chinese Medicine Extract with Potent Antioxidant and Anti-α-Glucosidase Activities

Process Biochemistry, 2023
Jiumn-Yih Wu, H. Ding, Tzi-Yuan Wang, Cheng-Zhi Cai, Te-Sheng Chang   +4 more
semanticscholar   +1 more source

Natural potential therapeutic agents of neurodegenerative diseases from the traditional herbal medicine Chinese dragon's blood.

Journal of Ethnopharmacology, 2014
Ning Li, Zhongjun Ma, Mujie Li, Yachao Xing, Yue Hou   +4 more
semanticscholar   +1 more source